HeartBeam
closing summary positive interactions with and internal milestones on track | HeartBeam
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
18 of 19
Related slides by other companies
Chimerix
Investor Presentation
August 2023
deal term summary emergent is an experienced company collaborating with government agencies to protect public health terms summary million received at closing in up to an additional million in potential procurement milestones royalty on future gross profit with volumes above million courses of therapy royalty of all international gross profit up to an additional million in development milestones a oral suspension tablets tembe me | Chimerix
Ocuphire Pharma
Results
October 2022
track record of achieving milestones | Ocuphire Pharma
Ocuphire Pharma
Investor Presentation
November 2023
summary to have a clinically meaningful impact on slowing or preventing progression to reduce likelihood of vision loss in diabetic patients owing | Ocuphire Pharma
Strategic Organizing Center
Activist
February 2024
questionable milestones | Strategic Organizing Center
Other recent decks by HeartBeam
See all presentations (3 decks)
Investor Presentation
October 2023
Results
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights